Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M90,378Revenue $M26,095Net Margin (%)4.5Z-Score2.3
Enterprise Value $M93,934EPS $1.0Operating Margin %7.9F-Score4
P/E(ttm))82.9Cash Flow Per Share $0Pre-tax Margin (%)4.5Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %4.7Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %-16.2Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-44.3ROA % (ttm)2.1Higher Current Ratio y-yN
Dividend Yield %3.9Insider Buy (3m)0ROE % (ttm)5.6Less Shares Outstanding y-yN
Payout Ratio %287Shares Outstanding M1,263ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AZNDavid Dreman 2014-12-31 Reduce-0.51%$67.15 - $75.38
($71.66)
$ 71.58-0%Reduce -75.42%28,764
AZNGeorge Soros 2014-12-31 Sold Out -0.08%$67.15 - $75.38
($71.66)
$ 71.58-0%Sold Out0
AZNMario Gabelli 2014-12-31 Reduce-0.01%$67.15 - $75.38
($71.62)
$ 71.58-0%Reduce -52.51%19,900
AZNCharles Brandes 2014-09-30 Sold Out -0.35%$68.49 - $76.31
($73.2)
$ 71.58-2%Sold Out0
AZNCharles Brandes 2014-06-30 Reduce-0.78%$62.45 - $81.09
($72.26)
$ 71.58-1%Reduce -71.06%386,058
AZNJoel Greenblatt 2014-06-30 Sold Out -0.09%$62.45 - $81.09
($72.26)
$ 71.58-1%Sold Out0
AZNGeorge Soros 2014-06-30 Buy 0.08%$62.45 - $81.09
($72.26)
$ 71.58-1%New holding150,000
AZNMario Gabelli 2014-06-30 Buy 0.02%$62.45 - $81.09
($72.26)
$ 71.58-1%New holding40,400
AZNNWQ Managers 2014-06-30 Reduce-0.01%$62.45 - $81.09
($72.26)
$ 71.58-1%Reduce -24.55%64,475
AZNHOTCHKIS & WILEY 2014-03-31 Sold Out -0.93%$58.51 - $68.38
($64.41)
$ 71.5810%Sold Out0
AZNCharles Brandes 2014-03-31 Reduce-0.84%$58.51 - $68.15
($64.29)
$ 71.5810%Reduce -46.73%1,333,894
AZNDavid Dreman 2014-03-31 Add0.14%$58.51 - $68.38
($64.41)
$ 71.5810%Add 26.61%135,439
AZNJoel Greenblatt 2014-03-31 Buy 0.09%$58.51 - $68.38
($64.41)
$ 71.5810%New holding95,518
AZNDavid Dreman 2013-12-31 Reduce-0.34%$49.72 - $59.5
($54.28)
$ 71.5824%Reduce -40.32%106,975
AZNHOTCHKIS & WILEY 2013-12-31 Reduce-0.3%$49.72 - $59.5
($54.28)
$ 71.5824%Reduce -24.90%3,689,214
AZNCharles Brandes 2013-09-30 Add0.12%$47.88 - $52.08
($50.24)
$ 71.5830%Add 7.92%2,381,040
AZNHOTCHKIS & WILEY 2013-06-30 Add0.68%$47.22 - $53.01
($50.92)
$ 71.5829%Add 131.18%4,944,742
AZNJoel Greenblatt 2013-06-30 Sold Out -0.24%$47.22 - $53.01
($50.92)
$ 71.5829%Sold Out0
AZNNWQ Managers 2013-03-31 Buy 0.03%$44.67 - $50.06
($47.4)
$ 71.5834%New holding78,400
AZNCharles Brandes 2012-12-31 Buy 1.2%$44.34 - $48.9
($46.77)
$ 71.5835%New holding2,188,735
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AZN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$17304.94view

Press Releases about AZN :

    Quarterly/Annual Reports about AZN:

      News about AZN:

      Articles On GuruFocus.com
      HealthCare Stocks That Can Make Investors Healthier Apr 08 2015 
      Regulus Therapeutics (RGLS) microRNA Therapeutic Milestone Payment, Dave & Buster's Entertainment (P Apr 08 2015 
      Pfizer Stocks Has A Lot Of Steam To Take The Investors Higher Jan 20 2015 
      Merck Takes A Step Forward In The World Of Medicine Jan 16 2015 
      Brandes International Equity Fund Q3 Commentary Dec 23 2014 
      Blackhill Bets Almost Half of Portfolio on Williams-Sonoma Nov 10 2014 
      A Look at the Top Five Medical Stocks Held in the Vanguard Portfolio Nov 09 2014 
      Steven Cohen Has a Track Record of Impressive Returns Jul 31 2014 
      I Believe AstraZeneca Is Fairly Valued Jul 16 2014 
      A Look at AstraZeneca’s New Drug on Diabetes May 22 2014 


      More From Other Websites
      AstraZeneca's Onglyza Briefing Documents Raise Concern - Analyst Blog Apr 13 2015
      Should The FDA Require CV Outcome Studies For Diabetes Drugs Before Approval? Apr 13 2015
      AstraZeneca and PatientsLikeMe announce global research collaboration Apr 13 2015
      8:01 am AstraZeneca and PatientsLikeMe announce five-year agreement to provide access to... Apr 13 2015
      FTSE dividends set to hit £86.3bn this year Apr 13 2015
      AstraZeneca joins Genomics England consortium Apr 12 2015
      VCs Play Matchmaker for CIOs Seeking Startup Tech Apr 10 2015
      Johnson & Johnson Earnings: 5 Key Things to Watch Apr 10 2015
      AstraZeneca's diabetes drug Onglyza may increase death rate -FDA Apr 10 2015
      UK's FTSE races to new record high as Shire shines Apr 10 2015
      AstraZeneca's Onglyza Ups Risk Of Death, FDA Says Apr 10 2015
      Lacker Favors June Fed Liftoff Even Amid Recent Weak Data Apr 10 2015
      Container Store's Virtue vs. Profit Apr 10 2015
      AstraZeneca Type-2 Diabetes Drug May Raise Death Risk, FDA Says Apr 10 2015
      Why AstraZeneca plc Beats GlaxoSmithKline plc Apr 10 2015
      Britain's FTSE nears record high as Shire shines Apr 10 2015
      Data suggests AstraZeneca drug may increase death rate - U.S FDA Apr 10 2015
      FDA: Data suggests AstraZeneca drug may increase death rate Apr 10 2015
      FDA: Data suggests AstraZeneca drug may increase death rate Apr 10 2015
      BUZZ-AstraZeneca: falls as FDA staff flag diabetes drug risk Apr 10 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK